Skip to main content

Neuroendocrine Involvement in Therapeutic Mechanisms of Neuroleptic and Antidepressant Drugs: Studies of Thyroid Axis

  • Chapter
Biological Psychiatry, Higher Nervous Activity
  • 22 Accesses

Summary

Sixty-five depressed and 33 paranoid hallucinatory patients were investigated longitudinally for one year to assess short- and long term therapeutic outcome with antidepressant and neuroleptic drugs, respectively. The patients’ thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) was studied at admission, during inpatient treatment and at discharge. Decreased TSH responses at outcome, and normalisation of these pathological responses during treatment were associated with the highest chance for recovery. TSH responses which persisted blunted at discharge were associated with a higher relapse rate during the one year following. It is hypothesized that the blunted TSH response may reflect a nonspecific cerebral malactivation, which is disactivated by the therapeutic effects of neuroleptic and antidepressant drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A.J. Prange, I.C. Wilson, P.P. Lara and L. Alltop, Effects of thyrotropin releasing hormone in depression, Lancet 2: 999–1002 (1972).

    Article  PubMed  Google Scholar 

  2. P.T. Loosen and A.J. Prange, Serum thyrotropin response to thyrotropin releasing hormone in psychiatric patients, A review, Am. J. Psychiatry 139, 4: 405–416 (1982).

    PubMed  CAS  Google Scholar 

  3. C. Kirkegaard, N. Norlem, U.B. Lauridsen and N. Bjorum, Prognostic value of the thyrotropin stimulation test in endogenous depression, Acta Psychiatrica Scandinavia 52: 170–177 (1975).

    Article  CAS  Google Scholar 

  4. G. Langer, G. Koinig, G. Schoenbeck, H. Aschauer and F. Resch, The therapeutic effects of antidepressants appear to involve neuroendocrine mechanisms, in “Biological psychiatry,” C. Perris, G. Struwe and B. Janssen, eds., Elsevier/North Holland (1981).

    Google Scholar 

  5. G. Langer, H. Aschauer, G. Koinig, H. Reiter, G. Schoenbeck and O. Lesch, Neuroendocrine factors in the treatment of schizophrenic patients: relationship with haloperidol level and treatment outcome, in: “Biological Psychiatry,” C. Perris, G. Struwe and B. Janssen, eds., Elsevier/North Holland (1981).

    Google Scholar 

  6. L. Kirkstein, M.S. Gold, D. Martin and A.L.C. Pottash, Clinical correlates of the TRH infusion test in primary depression, J. Clin. Psychiatry 43: 5, 191–194 (1982).

    Google Scholar 

  7. R.L. Spitzer, J. Endicott and E. Robins, “Research diagnostic criteria for a selected group of psychiatric disorders,” third edition, N.Y.S. psychiatric institute, New York 10032, (1978).

    Google Scholar 

  8. M. Hamilton, A rating scale for depression, J. neurol. psychiat 23: 56–62 (1960).

    Article  CAS  Google Scholar 

  9. J.E. Overall and D.R. Gorhem, The brief psychiatric rating scale, Psychol. Rep 10: 799–812 (1962).

    Article  Google Scholar 

  10. J. Wilber, A. Jaffer, L. Jacobs and R.D. Utinger, Inhibition of TRH stimulated TSH secretion in man by a single dose of thyroid hormone, Horm. Metab. Res. 4: 508 (1972).

    Article  PubMed  CAS  Google Scholar 

  11. G. Langer, G. Schoenbeck, G. Koinig and H. Aschauer, Neuroendocrine mechanisms in the therapeutic effects of antidepressant drugs: The thyroid axis hypothesis, in: “Typical and atypical antidepressants,” E. Costa and G. Racagni, eds., Raven Press, New York (1982).

    Google Scholar 

  12. F.K. Goodwin, A.J. Prange, R.M. Post, G. Muscettola and M.A. Lipton, Potentiation of antidepressant effects by L-trijodthyronine in tricyclic nonresponders, Am. J. Psychiat 139: 1, 34–36 (1982).

    PubMed  CAS  Google Scholar 

  13. J. Tuomisto, Neuropharmacological intervention on the pituitary-hypothalamic relationship, Ann, clin. res. 10: 120–132 (1978).

    CAS  Google Scholar 

  14. S.L. Horacz, The dopamine hypothesis, Schizophrenia Bulletin 8, 3: 438–470 (1982).

    Article  Google Scholar 

  15. H. Heimann, Auf dem Wege zu einer einheitlichen psychophysiologischen Theorie depressiver Syndrome, Praxis Psychother. Psychosom. 24: 281–299 (1979).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Langer, G., Aschauer, H., Keshaven, M.S., Koinig, G., Resch, F., Schoenbeck, G. (1985). Neuroendocrine Involvement in Therapeutic Mechanisms of Neuroleptic and Antidepressant Drugs: Studies of Thyroid Axis. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Biological Psychiatry, Higher Nervous Activity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8329-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8329-1_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8331-4

  • Online ISBN: 978-1-4684-8329-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics